Class Action Lawsuit Launched for Zynex, Inc. Shareholders Amid Allegations of Fraudulent Practices

Zynex, Inc. Faces Class Action Lawsuit for Alleged Fraud

In a development that has sent shockwaves through the investment community, Zynex, Inc., a company listed on the OTC markets under the ticker ZYXIQ, is the focus of a burgeoning class action lawsuit initiated by The Gross Law Firm. Shareholders who purchased ZYXIQ stock between February 25, 2021, and December 15, 2025, are being called upon to seek potential recovery for losses attributed to misleading statements and serious allegations against the company's practices.

The lawsuit alleges that during the designated class period, Zynex engaged in practices that significantly misrepresented its financial health and operational success. Specific allegations include that Zynex shipped excess products, leading to inflated revenue figures that misled investors regarding the company’s growth metrics. Furthermore, the complaint highlights that the company faced scrutiny from insurers due to claims it made that were deemed fraudulent, specifically noting an action commenced by Travelers in August 2023 that accused Zynex of participating in an illicit overbilling scheme.

The implications of these allegations are grave, not only for Zynex’s stakeholders but also for the management team, which is accused of prioritizing aggressive sales tactics over compliance with standard operational laws and regulations. Observers note that the company's prioritization of sales growth over ethical practices may have contributed to a deep-seated culture of illegality, as management allegedly allowed false claims to proliferate unchecked.

Additionally, the lawsuit points to an apparent disregard for the establishment of a robust internal control environment, which is foundational for any publicly traded company. Shareholders may recall that on August 21, 2023, the lawsuit against Zynex, including its executives, was filed, alleging that the company had engaged in fraudulent practices over a sustained period, culminating in damages exceeding $23 million.

As part of the ongoing legal processes, affected shareholders are encouraged to register with The Gross Law Firm as potential lead plaintiffs as the filing deadline approaches on April 21, 2026. Although lead plaintiff status is not a prerequisite for participation in the case recovery, those who step forward will receive portfolio monitoring services to keep them informed on the case’s progress.

The Gross Law Firm, known for its advocacy of shareholder rights and addressing corporate malfeasance, aims to ensure accountability in the financial markets. They seek redress for investors who suffered losses due to Zynex's alleged fraudulent practices, an endeavor crucial for reinstating integrity in corporate governance.

In light of these developments, shareholders of Zynex, Inc. are urged to take action without delay to secure their rights and potentially mitigate their financial losses. By joining this class action, they will not only be fighting for their investments but also pushing for stricter adherence to ethical business practices within publicly traded companies. For more detailed information on how to participate in this class action, interested parties can visit The Gross Law Firm’s official webpage dedicated to this issue.

In conclusion, the allegations against Zynex highlight critical issues regarding corporate compliance, accountability, and transparency. As the legal battle unfolds, it serves as a reminder to investors about the importance of vigilance and due diligence when engaging in the stock market.